Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5832824, 10 pages
https://doi.org/10.1155/2017/5832824
Research Article

Combination Treatment with PPARγ Ligand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells

Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea

Correspondence should be addressed to Chang-Nim Im; moc.liamg@dubylim

Received 15 February 2017; Revised 12 April 2017; Accepted 24 April 2017; Published 31 May 2017

Academic Editor: Marta M. Alonso

Copyright © 2017 Chang-Nim Im. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Gurney and N. Kadan-Lottick, “Brain and other central nervous system tumors: rates, trends, and epidemiology,” Current Opinion in Oncology, vol. 13, no. 3, pp. 160–166, 2001. View at Publisher · View at Google Scholar
  2. X. Zhang, W. Zhang, X. Mao, H. Zhen, W. Cao, and S. Hu, “Targeting role of glioma stem cells for gliobastoma multiforme,” Current Medicinal Chemistry, vol. 20, no. 15, pp. 1974–1984, 2013. View at Publisher · View at Google Scholar
  3. M. Jackson, F. Hassiotou, and A. Nowak, “Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target,” Carcinogenesis, vol. 36, no. 2, pp. 177–185, 2015. View at Publisher · View at Google Scholar
  4. A. Chawla, E. J. Schwarz, D. D. Dimaculangan, and M. A. Lazar, “Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation,” Endocrinology, vol. 135, no. 2, pp. 798–800, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kato, T. Nagaya, M. Fujieda, K. Saito, J. Yoshida, and H. Seo, “Expression of PPARγ and its ligand-dependent growth inhibition in human brain tumor cell lines,” Japanese Journal of Cancer Research, vol. 93, no. 6, pp. 660–666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. Lee, D. S. Kim, H. R. Kim et al., “Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma) agonist, independently of PPARgamma in human glioma cells,” Biophysical Research Communications, vol. 417, no. 1, pp. 552–557, 2012. View at Publisher · View at Google Scholar
  7. D. W. Kang, C. H. Choi, J. Y. Park, S. K. Kang, and Y. K. Kim, “Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells,” Neurochemical Research, vol. 33, no. 3, pp. 551–561, 2008. View at Publisher · View at Google Scholar
  8. D. C. Liu, C. B. Zang, H. Y. Liu, K. Possinger, S. G. Fan, and E. Elstner, “A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells,” Acta Pharmacologica Sinica, vol. 25, no. 10, pp. 1312–1319, 2004. View at Google Scholar
  9. R. Morosetti, T. Servidei, M. Mirabella et al., “The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines,” International Journal of Oncology, vol. 25, no. 2, pp. 493–502, 2004. View at Publisher · View at Google Scholar
  10. N. Strakova, J. Ehrmann, P. Dzubak, J. Bouchal, and Z. Kolar, “The synthetic ligand of peroxisome proliferator-activated receptor-γ ciglitazone affects human glioblastoma cell lines,” Journal of Pharmacology and Experimental Therapeutics, vol. 309, no. 3, pp. 1239–1247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Strakova, J. Ehrmann, J. Bartos, J. Malikova, J. Dolezel, and Z. Kolar, “Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors,” Neoplasma, vol. 52, no. 2, pp. 126–136, 2005. View at Google Scholar
  12. K. L. Schaefer, K. Wada, H. Takahashi et al., “Peroxisome proliferator-activated receptor γ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells,” Cancer Research, vol. 65, no. 6, pp. 2251–2259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. P. Ellis and K. M. Kurian, “Biological rationale for the use of PPARgamma agonists in glioblastoma,” Frontiers in Oncology, vol. 4, p. 52, 2014. View at Google Scholar
  14. W. Chearwae and J. J. Bright, “PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells,” British Journal of Cancer, vol. 99, no. 12, pp. 2044–2053, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Grommes, D. S. Conway, A. Alshekhlee, and J. S. Barnholtz-Sloan, “Inverse association of PPARγ agonists use and high grade glioma development,” Journal of Neuro-Oncology, vol. 100, no. 2, pp. 233–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Pestereva, S. Kanakasabai, and J. J. Bright, “PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells,” British Journal of Cancer, vol. 106, no. 10, pp. 1702–1712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Karpel-Massler, M. A. Westhoff, S. Zhou et al., “Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells,” Molecular Cancer Therapeutics, vol. 12, no. 9, pp. 1783–1795, 2013. View at Publisher · View at Google Scholar
  18. G. Karpel-Massler, C. Shu, L. Chau et al., “Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo,” Oncotarget, vol. 6, pp. 14507–14521, 2015. View at Publisher · View at Google Scholar
  19. S. Liang, G. Shen, Q. Liu et al., “Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis,” Proteomics–Clinical Applications, vol. 3, no. 6, pp. 743–753, 2009. View at Publisher · View at Google Scholar
  20. X. Yang, W. Cao, H. Lin et al., “Isoform-specific expression of 14-3-3 proteins in human astrocytoma,” Journal of the Neurological Sciences, vol. 276, no. 1-2, pp. 54–59, 2009. View at Publisher · View at Google Scholar
  21. L. Cao, W. Cao, W. Zhang et al., “Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry,” Neuroscience Letters, vol. 432, no. 2, pp. 94–99, 2008. View at Publisher · View at Google Scholar
  22. F. H. Gong, G. L. Wang, J. Ye, T. D. Li, H. M. Bai, and W. M. Wang, “14-3-3 beta regulates the proliferation of glioma cells through the GSK3 beta/beta-catenin signaling pathway,” Oncology Reports, vol. 30, no. 6, pp. 2976–2982, 2013. View at Google Scholar
  23. T. C. Chang, C. C. Liu, E. W. Hsing et al., “14-3-3 sigma regulates beta-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3 beta,” PLoS ONE, vol. 7, no. 6, 2012. View at Google Scholar
  24. Y. H. Jin, Y. J. Kim, D. W. Kim et al., “Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53,” Biochemical and Biophysical Research Communications, vol. 368, no. 3, pp. 690–695, 2008. View at Publisher · View at Google Scholar
  25. H. Hermeking, “The 14-3-3 cancer connection,” Nature Reviews Cancer, vol. 3, no. 12, pp. 931–943, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. K. K. Wu, “Peroxisome proliferator-activated receptors protect against apoptosis via 14-3-3,” PPAR Research, vol. 2010, Article ID 417646, 7 pages, 2010. View at Publisher · View at Google Scholar
  27. K. K. Wu and J. Y. Liou, “Cyclooxygenase inhibitors induce colon cancer cell apoptosis via PPARdelta → 14-3-3epsilon pathway,” Methods in Molecular Biology, vol. 512, pp. 295–307, 2009. View at Google Scholar
  28. J. Lee, T. Takahashi, N. Yasuhara, J. Inazawa, S. Kamada, and Y. Tsujimoto, “Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death,” Oncogene, vol. 18, no. 46, pp. 6183–6190. View at Publisher · View at Google Scholar
  29. S. Takayama, Z. Xie, and J. C. Reed, “An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators,” Journal of Biological Chemistry, vol. 274, no. 2, pp. 781–786, 1999. View at Publisher · View at Google Scholar
  30. H. Doong, K. Rizzo, S. Fang, V. Kulpa, A. M. Weissman, and E. C. Kohn, “CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation,” Journal of Biological Chemistry, vol. 278, no. 31, pp. 28490–28500, 2003. View at Publisher · View at Google Scholar
  31. A. Gentilella and K. Khalili, “BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner,” Journal of Biological Chemistry, vol. 286, no. 11, pp. 9205–9215, 2011. View at Publisher · View at Google Scholar
  32. M. Festa, L. Del Valle, K. Khalili et al., “BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy,” The American Journal of Pathology, vol. 178, no. 6, pp. 2504–2512, 2011. View at Publisher · View at Google Scholar
  33. C. N. Im, H. HyeonYun, B. Song et al., “BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes,” Oncotarget, vol. 7, no. 23, pp. 35056–35070, 2016. View at Publisher · View at Google Scholar
  34. C. N. Im, H. H. Yun, H. J. Yoo, M. J. Park, and J. H. Lee, “Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions,” Oncology Reports, vol. 34, no. 2, pp. 920–928, 2015. View at Publisher · View at Google Scholar
  35. C. N. Im, “Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands,” IUBMB Life, vol. 68, no. 3, pp. 173–177, 2016. View at Publisher · View at Google Scholar
  36. S. A. Mani, W. Guo, and M.-J. Liao, “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Gabelloni, E. Da Pozzo, S. Bendinelli et al., “Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma,” Neuroscience, vol. 168, no. 2, pp. 514–522, 2010. View at Publisher · View at Google Scholar
  38. S. An, D. He, E. Wagner, and C. Jiang, “Peptide-like polymers exerting effective glioma-targeted siRNA delivery and release for therapeutic application,” Small, vol. 11, no. 38, pp. 5142–5150, 2015. View at Publisher · View at Google Scholar
  39. K. Yasui, M. Shimamura, N. Mitsutake, and Y. Nagayama, “SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells,” Thyroid, vol. 23, no. 8, pp. 989–996, 2013. View at Publisher · View at Google Scholar
  40. C. N. Im, H. H. Yun, and J. H. Lee, “Heat shock factor 1 depletion sensitizes A172 glioblastoma cells to temozolomide via suppression of cancer stem cell-like properties,” International Journal of Molecular Sciences, vol. 18, no. 2, p. 468, 2017. View at Publisher · View at Google Scholar
  41. K. H. Kim, Y. S. Cho, J. Park, S. Yoon, K. Kim, and A. Chung, “Pro-MMP-2 activation by the PPARγ agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK,” FEBS Letters, vol. 581, no. 17, pp. 3303–3310, 2007. View at Publisher · View at Google Scholar
  42. S. B. Seo, J. Lee, H. H. Yun et al., “14-3-3β depletion drives a senescence program in glioblastoma cells through the ERK/SKP2/p27 pathway,” Molecular Neurobiology. View at Publisher · View at Google Scholar
  43. C. Frasson, E. Rampazzo, B. Accordi et al., “Inhibition of PI3K signalling selectively affects medulloblastoma cancer stem cells,” BioMed Research International, vol. 2015, Article ID 973912, 11 pages, 2015. View at Publisher · View at Google Scholar
  44. S. R. Datta, H. Dudek, X. Tao et al., “Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery,” Cell, vol. 91, no. 2, pp. 231–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. Lee, J. S. Lee, M. N. Cui et al., “BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells,” Cell Death and Disease, vol. 5, no. 11, p. e1537, 2014. View at Publisher · View at Google Scholar